XML 32 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Operations and Comprehensive Loss (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Revenue:        
Net product revenue $ 6,897 $ 8,453 $ 22,693 $ 26,368
Contract revenue 0 0 0 8,462
Service and other revenue 271 0 398 0
Total revenue 7,168 8,453 23,091 34,830
Operating expenses:        
Cost of sales 5,354 4,249 14,144 13,478
Royalty expense 281 325 901 997
Research and development 2,544 3,660 9,358 16,005
Selling, general and administrative 10,011 10,857 36,491 37,574
Restructuring 0 0 876 0
Total operating expenses 18,190 19,091 61,770 68,054
Loss from operations (11,022) (10,638) (38,679) (33,224)
Other income (expense):        
Interest income 1 11 12 40
Interest expense (1,587) (3,463) (4,795) (8,730)
Change in fair value of warrant liabilities 215 (3,569) (2,780) (3,611)
Change in fair value of embedded derivatives 1,474 (202) 912 166
Other income (expense) 67 (1,421) 90 (1,379)
Total other income (expense) 170 (8,644) (6,561) (13,514)
Net loss before income taxes (10,852) (19,282) (45,240) (46,738)
Provision for income taxes 0 0 0 (5)
Net loss (10,852) (19,282) (45,240) (46,743)
Net loss per share, basic and diluted (usd per share) $ (0.10) $ (0.21) $ (0.44) $ (0.63)
Weighted average shares outstanding, basic and diluted 104,682 90,370 102,136 73,790
Comprehensive loss $ (10,852) $ (19,282) $ (45,240) $ (46,743)